---
This issue on patent foramen ovale (PFO) is dedicated to my oncologist, Alexandra Drakaki, MD, and the researchers who developed immunotherapy. Without their support, I would not have been alive to help write and edit this compendium on PFO. I had a nephrectomy for renal cell carcinoma in April 2023 and began immunotherapy for metastatic disease in November 2023. I appreciate the opportunity I have been given to describe the research in this field over the past 25 years.
Source: Cardiology Clinics - Category: Cardiology Authors: Jonathan M. Tobis Tags: Dedication Source Type: research
More News: Cancer & Oncology | Carcinoma | Cardiology | Heart | Immunotherapy | Kidney Cancer | Nephrectomy | Patent Foramen Ovale | Renal Cell Carcinoma